ѻý

6% of Seniors Depressed; ADHD and Hormones; Novel Antipsychotic Eases Schizophrenia

<ѻý class="mpt-content-deck">— News and commentary from the psychiatry world
MedpageToday
Illustration of a brain shaped maze.

A study of older adults showed that , with higher prevalences in certain groups, including women, those who were unmarried, and those with chronic medical conditions. (Journal of the American Geriatrics Society)

A single significantly improved depressive symptoms by week 3 among participants with severe treatment resistance in a small single-arm open-label trial. (American Journal of Psychiatry)

Older adults with major depressive disorder compared with those without depression, according to a prospective longitudinal cohort study. (JAMA Network Open)

Navacaprant, an investigational kappa opioid receptor antagonist, for alleviating depression symptoms in the phase III KOASTAL-1 study, said developer Neumora.

Symptoms of attention deficit-hyperactivity disorder (ADHD) may , a study suggested. (Scientific American)

Prenatal exposure to systemic glucocorticoids was tied to an , a large cohort study of Danish infants showed. (JAMA Network Open)

Individuals ineligible for ADHD medication trials , such as higher rates of psychiatric hospitalizations and specialist care visits related to substance use disorder, depression, and anxiety, according to a Swedish population-based study. (Lancet Psychiatry)

Investigational LB-102 -- a potential first-in-class benzamide antipsychotic -- after 4 weeks with all three doses tested in a phase II trial, said LB Pharmaceuticals.

A by two fellow patients at Maryland's Clifton T. Perkins Hospital Center, a maximum-security forensic psychiatric facility. (Washington Post)

Mothers treated with selective serotonin reuptake inhibitors tended that could have health risks for infants, a cross-sectional study suggested. (JAMA Network Open)

Here's for people with Alzheimer's disease or dementia. (The Atlantic)

  • author['full_name']

    Kristen Monaco is a senior staff writer, focusing on endocrinology, psychiatry, and nephrology news. Based out of the New York City office, she’s worked at the company since 2015.